Repligen Announces Agreement to Acquire ARTeSYN Biosolutions
Strategic Move
to Expand
Single-Use
Bioprocessing
Systems,
Components
and Flow Paths
R REPLIGEN
3
Gold Standard in
Single-Use Systems
ARTESYN Biosolutions is an
innovator and a market leader in
fully automated CGMP single-use
Chromatography, Filtration and
Buffer/Media Prep Systems and
Flow Paths
Vertical Integration with
EMT and ProConnex®
EMT key provider of silicone
liners and assemblies (July 2020)
Complements and expands
ProConnex flow paths
Full control of supply chain
Complements, Expands
RGEN's Systems Portfolio
beyond Hollow Fiber Filtration
Adds Systems for Flat sheet Filtration,
Chromatography and Buffer Prep
Adds leading innovator in
downstream continuous
manufacturing
Future integration of FlowVPE to
further differentiate RGEN Systems
Foundation for Systems in
Gene Therapy
Filtration and Chromatography
solutions
Very low hold up volumes - minimizes
product losses and differentiates
versus competition
Expands Total
Addressable Market
Adds ~$0.2B to addressable
market bringing total to ~$3.2B
Addresses all biologic types
mAbs
●
●
rProteins
Vaccines
Cell & Gene Therapy
Meets Repligen's
M&A Criteria
Highly differentiated technology
Addresses gaps in Filtration and
Chromatography Systems
Strong revenue growth
Accretive to adj. EPS in 2022
Market leader, SU innovator, Expands RGEN Systems, Accretive 2022
ARTESYN
BiosolutionsView entire presentation